New Jersey Drug Utilization Review Board Agenda April 2026
Gainwell Provides Q4 2025 Prior Authorization Report
Trusted by teams at
Description
The New Jersey Drug Utilization Review Board agenda notes that Gainwell Technologies produced the NJ MCO 4th Quarter 2025 Prior Authorization Report, reflecting ongoing technology and reporting services to support Medicaid pharmacy oversight. No specific contract amount or term changes are detailed in the agenda.
Contract Details
Vendor
GAINWELL TECHNOLOGIES
Agency
NJ Department of Human Services, NJ
Contract Type
TECHNOLOGY
Document Date
April 15, 2026
Contract Term
4th Quarter 2025
More from GAINWELL TECHNOLOGIES
Related Contracts
Cherokee County Board of Commissioners Meeting Agenda 2026-05-18
PENDINGDepartment of Health Care Policy & Financing Case Management Agency Director Meeting Report February 2026
ONGOINGNew Jersey Drug Utilization Review Board Agenda January 2026
ONGOINGIndiana Family and Social Services Administration Medicaid Oversight Committee Report Jan 2026
ONGOINGshawano-county-community-services-advisory-committee-meeting-agenda_dc7.pdf
ongoingMore from NJ Department of Human Services
nj-department-of-human-services-drug-utilization-review-board-agenda-october-2025_148.pdf
nj-dhs-durb-agenda-drug-protocol-updates-utilization-trends-jul-16-2025_a3a.pdf
nj-dept-of-human-services-durb-agenda-drug-utilization-protocol-reviews-july-16-2025_b3a.pdf
nj-department-of-human-services-agenda-2025-04-23_0b7.pdf
nj-department-of-human-services-agenda-2025-04-23_0b7.pdf
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.